Phialogics
Key Facts
| Invested since | 2022 |
| Based in | Allschwil |
About the company
Phialogics is an innovative start-up in the field of autoimmune diseases. Founded in 2021 by a team of widely recognized experts in protein engineering and immunology, the company based in Basel (CH) and Heidelberg (GER) is committed to making a decisive contribution to the autoimmune disease space. The founding team is backed by strong Scientific Advisory and Supervisory Boards, which puts the company in a good position to move fast on the lead candidate and develop novel biologics.
Do you want to
know more about this company?
Zum Artikel
Dr. Katharina Severin Senior Investment Manager
Dr. Katharina SeverinSenior Investment Manager
Phialogics in the news
zum Artikel